Schmalzing, Marc http://orcid.org/0000-0002-3289-2299
Kellner, Herbert
Askari, Ayman
De Toro Santos, Javier
Vazquez Perez-Coleman, Julio Cesar
Foti, Rosario
Jeka, Sławomir
Haraoui, Boulos
Allanore, Yannick
Peichl, Peter
Oehri, Martin
Rahman, Masiur
Furlan, Fabricio
Romero, Elisa
Hachaichi, Sohaib
Both, Charlotte
Brueckmann, Ines
Sheeran, Tom
Funding for this research was provided by:
This study was funded by Hexal AG, a Sandoz company.
Universitätsklinikum Würzburg
Article History
Received: 22 June 2023
Accepted: 3 October 2023
First Online: 11 November 2023
Declarations
:
: Marc Schmalzing: Compensation for consultancies: Chugai/Roche, Hexal/Sandoz, Gilead, AbbVie, Janssen-Cilag, Boehringer/Ingelheim, onkowissen.de, EUSA-Pharma, Novartis, AstraZeneca, Amgen, medac, Lilly, Galapagos, UCB; Speaker’s fees: Novartis, AbbVie, AstraZeneca, Chugai/Roche, Janssen-Cilag, Gilead, Boehringer/Ingelheim, Mylan, Galapagos, EUSA-Pharma; Travel grants: Chugai/Roche, Boehringer/Ingelheim, Celgene, Medac, UCB, Mylan, Galapagos. Herbert Kellner: Speaker’s bureau: Abbvie, Boehringer, Biogen, Celgene, Celltrion, Fresenius, Galapagos, Hexal, Janssen, Lilly, Medac, MSD, Viatris, Novartis, UCB, Sandoz, Sanofi-Aventis. Ayman Askari: None. Javier De Toro Santos: Consulting fees from Sandoz, AbbVie, Lilly, Janssen-Cilag, Novartis, Galapagos, UCB. Julio Cesar Vazquez Perez-Coleman: Consulting fees from Sandoz, AbbVie, Novartis. Rosario Foti: None. Sławomir Jeka: Consulting fees from Sandoz, UCB, Lilly, Novartis, Abbvie, Roche, Celgene, Gilead, AstraZeneca. Boulos Haraoui: Research grants, Consulting fees: Abbvie, Amgen, Lilly, Pfizer, Sandoz. Yannick Allanore: Consulting fees from Sandoz, Celltrion. Peter Peichl: None. Martin Oehri: None. Masiur Rahman: Employee of Sandoz. Fabricio Furlan: Former employee of Sandoz. New affiliation: STADA. Elisa Romero: Employee of Sandoz. Sohaib Hachaichi: Former employee of Sandoz. New affiliation: Bayer AG. Charlotte Both: Employee of Sandoz. Ines Brueckmann: Employee of Sandoz. Tom Sheeran: Consultant fees from Novartis, Pfizer, Roche, BMS.
: The study was approved for each participating site according to the local regulations. All patients signed an informed consent form that was reviewed and approved by an independent ethics committee or institutional review board. The study design was reviewed by the ethics committees or institutional review boards, and the study was conducted in accordance with the principle of the Declaration of Helsinki. Details of the institutional review boards and ethics committees can be found in Supplementary Table 7.